Myelination in Multiple Sclerosis Lesions Is Associated with Regulation of Bone Morphogenetic Protein 4 and Its Antagonist Noggin

Remyelination is a central aspect of new multiple sclerosis (MS) therapies, in which one aims to alleviate disease symptoms by improving axonal protection. However, a central problem is mediators expressed in MS lesions that prevent effective remyelination. Bone morphogenetic protein4 (BMP4) inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales: Harnisch, Kim, Teuber-Hanselmann, Sarah, Macha, Nicole, Mairinger, Fabian, Fritsche, Lena, Soub, Daniel, Meinl, Edgar, Junker, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337410/
https://www.ncbi.nlm.nih.gov/pubmed/30609838
http://dx.doi.org/10.3390/ijms20010154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337410/
https://www.ncbi.nlm.nih.gov/pubmed/30609838
http://dx.doi.org/10.3390/ijms20010154

Ejemplares similares